Implementation of a fast method for the measurement of carnitine palmitoyltransferase 2 activity in lymphocytes by tandem mass spectrometry as confirmation for newborn screening
- 8 April 2019
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 42 (5) , 850-856
Abstract
Carnitine palmitoyltransferase II (CPT2) is a rare autosomal recessive inherited disorder affecting mitochondrial β‐oxidation. Confirmation diagnostics are mostly based on molecular sequencing of the CPT2 gene, especially to distinguish CPT2 and carnitine aclycarnitine translocase (CACT) deficiencies, which present with identical acylcarnitine profiles on newborn screening. In the past different enzyme tests in muscle biopsies have been developed in order to study the functional effect in one of the main target organs. In this study we implemented a method for measurement of CPT2 enzyme activity in human lymphocytes with detection of the reaction products via LC‐MS/MS to enable the simultaneous evaluation of the functional impairment and the clear diagnosis of the disease. CPT2 activity was measured in samples collected from CPT2 patients (n=11), heterozygous carriers (n=6) and healthy individuals (n=52). Seven patients out of 11 were homozygous for the common mutation c.338T>C and showed a residual activity with median values of 19.2 ± 3.7% of healthy controls. Heterozygous carriers showed a residual activity in the range of 42‐75%. Four individuals carrying the heterozygous mutation c.338T>C showed a two‐fold higher residual activity as compared to homozygous individuals. Our optimized method for the measurement of CPT2 activity is able to clearly discriminate between patients and healthy individuals and offers the possibility to determine CPT2 activity in human lymphocytes avoiding the need of an invasive muscle biopsy. This method can be successfully used for confirmation diagnosis in case of positive NBS and would markedly reduce the time to define diagnosis.Keywords
This publication has 31 references indexed in Scilit:
- Enhanced interpretation of newborn screening results without analyte cutoff valuesGenetics in Medicine, 2012
- The enzymology of mitochondrial fatty acid beta‐oxidation and its application to follow‐up analysis of positive neonatal screening resultsJournal of Inherited Metabolic Disease, 2010
- Carnitine supplementation induces long‐chain acylcarnitine production—Studies in the VLCAD‐deficient mouseJournal of Inherited Metabolic Disease, 2005
- Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspectsMolecular Aspects of Medicine, 2004
- Phenotypic variability among first‐degree relatives with carnitine palmitoyltransferase II deficiencyMuscle & Nerve, 2002
- Distinct Kinetics of Carnitine Palmitoyltransferase I in Contact Sites and Outer Membranes of Rat Liver MitochondriaJournal of Biological Chemistry, 2001
- Reconstitution of purified, active and malonyl-CoA-sensitive rat liver carnitine palmitoyltransferase I: relationship between membrane environment and malonyl-CoA sensitivityBiochemical Journal, 2000
- Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscleEuropean Journal of Biochemistry, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Muscle Carnitine Palmityltransferase Deficiency and MyoglobinuriaScience, 1973